Novabay Pharmaceuticals Inc Ret. on equity
What is the Ret. on equity of Novabay Pharmaceuticals Inc?
The Ret. on equity of Novabay Pharmaceuticals Inc is -431.13%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Health Care sector on NYSEMKT compared to Novabay Pharmaceuticals Inc
What does Novabay Pharmaceuticals Inc do?
novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across
Companies with ret. on equity similar to Novabay Pharmaceuticals Inc
- CAT Strategic Metals has Ret. on equity of -436.41%
- Hapbee Technologies has Ret. on equity of -435.95%
- Super League Gaming has Ret. on equity of -435.27%
- Indivior PLC has Ret. on equity of -435.19%
- Guardant Health Inc has Ret. on equity of -432.71%
- Biondvax Pharmaceuticals Ltd has Ret. on equity of -432.25%
- Novabay Pharmaceuticals Inc has Ret. on equity of -431.13%
- Core Gold has Ret. on equity of -430.83%
- Alnylam Pharmaceuticals has Ret. on equity of -430.74%
- Alnylam Pharmaceuticals has Ret. on equity of -430.74%
- Spectur has Ret. on equity of -430.03%
- Midas Gold has Ret. on equity of -428.98%
- Kalo Gold has Ret. on equity of -427.81%